Today, Reframe Cancer has launched its cancer screening proposition, offering access to screenings for bowel, cervical, prostate, lung, breast, and skin cancers.
Today, Swiss Re has announced the appointment of Bernhard Kaufmann as Chief Risk Officer (CRO), succeeding Patrick Raaflaub as of the 1st October 2025.